Organon (OGN) Times Interest Earned (2021 - 2026)
Organon (OGN) recorded quarterly Times Interest Earned of $2.12 in Q1 2026, up 21.99% quarter-over-quarter from $1.74 in Q4 2025, and up 9.84% on a YoY basis from $1.93 in Q1 2025.
Organon (OGN) Times Interest Earned (2021 - 2026) Analysis & Trends
Organon's Times Interest Earned history runs 6 years deep, the most recent figure standing at $2.12 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 9.84% year-over-year to $2.12; the TTM figure through Mar 2026 stood at $2.3 (down 11.07% YoY), while the FY2025 annual figure was $2.24, up 590.48% from the prior year.
- Times Interest Earned was $2.12 for Q1 2026 at Organon, up from $1.74 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $3.26 in Q3 2024 to a low of -$4.49 in Q4 2023.
- Historically, Times Interest Earned has averaged -$0.51 across 5 years, with a median of -$1.23 in 2022.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned tumbled 113.04% in 2023, then soared 200.76% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$4.06 in 2022, then slipped by 10.58% to -$4.49 in 2023, then soared by 148.61% to $2.18 in 2024, then dropped by 20.45% to $1.74 in 2025, then grew by 21.99% to $2.12 in 2026.
- The last three Times Interest Earned figures came in at $2.12 (Q1 2026), $1.74 (Q4 2025), and $2.8 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | - |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | - |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | - |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 2.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 |
| Dec 31, 2025 | 1.74 |
| Sep 30, 2025 | 2.80 |
| Jun 30, 2025 | 2.47 |
| Mar 31, 2025 | 1.93 |
| Dec 31, 2024 | 2.18 |
| Sep 30, 2024 | 3.26 |
| Jun 30, 2024 | 2.95 |
| Mar 31, 2024 | -3.27 |
| Dec 31, 2023 | -4.49 |
| Sep 30, 2023 | -3.97 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -2.61 |
| Dec 31, 2022 | -4.06 |
| Sep 30, 2022 | -2.49 |
| Jun 30, 2022 | -3.07 |
| Mar 31, 2022 | -1.23 |
| Dec 31, 2021 | -3.70 |
| Sep 30, 2021 | -2.24 |
| Jun 30, 2021 | -2.35 |